J.W. Cole Advisors’s Rockwell Medical RMTI Stock Holding History

J.W. Cole Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-363	Closed	-$43K	–	836
2020 Q3	$43K	Buy	+363	New	+$62.8K	﹤0.01%	749

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

J.W. Cole Advisors's RMTI Position: Q4 2020 in Review

J.W. Cole Advisors sold out of Rockwell Medical (RMTI) in Q4 2020, closing a stake of 363 shares — an estimated $43K sold.

J.W. Cole Advisors first reported a position in RMTI in Q3 2020 and held it in 1 quarter. The position peaked at $43K in Q3 2020. 91 funds tracked by Wall St. Rank hold RMTI as of Q4 2020.

J.W. Cole Advisors reported no remaining Rockwell Medical position as of Q4 2020 after selling out during the quarter.
J.W. Cole Advisors sold 363 Rockwell Medical shares in Q4 2020, an estimated $43K.
J.W. Cole Advisors first reported a position in Rockwell Medical in Q3 2020 and held it in 1 quarter.
J.W. Cole Advisors's Rockwell Medical position peaked at $43K in Q3 2020.
91 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2020.

Based on J.W. Cole Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.